Mer2 Antibody, Rabbit, Polyclonal

Catalog Number: ROC-600-401-925
Article Name: Mer2 Antibody, Rabbit, Polyclonal
Biozol Catalog Number: ROC-600-401-925
Supplier Catalog Number: 600-401-925
Alternative Catalog Number: ROC-600-401-925
Manufacturer: Rockland Immunochemicals
Host: Rabbit
Category: Antikörper
Application: ELISA, WB
Species Reactivity: Yeast
Immunogen: This affinity purified antibody was prepared from whole rabbit serum produced by repeated immunizations with a synthetic peptide corresponding to amino acids 26-35 of Saccharomyces cerevisiae Mer2 protein.
Conjugation: Unconjugated
Alternative Names: rabbit anti-Mer2 antibody, Meiotic recombination 2 protein, Recombination protein 107, REC107, YJR021C, J1462
Clonality: Polyclonal
Concentration: 0.75 mg/mL by UV absorbance at 280 nm
NCBI: 853478
UniProt: P21651
Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Form: Liquid (sterile filtered)
Target: Saccharomyces cerevisiae
Antibody Type: Primary Antibody
Application Dilute: ELISA: 1:5,000 - 1:25,000, IP: 1:100, WB: 1:1,000 - 1:10,000
Application Notes: This affinity purified antibody has been tested for use in ELISA and by western blot. Specific conditions for reactivity should be optimized by the end user. Expect a band approximately 50 kDa in size corresponding to Mer2 protein by western blotting in
Western blot using Rocklands affinity purified anti-S.cerevisiae Mer2 antibody shows detection of phosphorylated and unphosphorylated Mer2 in wild type, phosphatase treated and mutant cells. Lane 1 contains Mer2-myc protein detected in wild type cells after first immunoprecipitating the protein using anti-myc antibody. Cells were harvested 4 h after the initiation of meiosis and therefore contain mostly phosphorylated Mer2. Lane 2 contains the same preparation after treatment with phosphatase. Lane 3 contains Mer2-S30A protein as a phosphorylation control. This antibody is reactive with both phosphorylated and unphosphorylated Mer2 at the S30 position. The primary antibody was used at a 1:5,000 dilution. Personal Communication. Michael Lichten, NIH, CCR, Bethesda, MD.